New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
ICON Public Limited Company
ICLR
Shape
US Flag

NASDAQ

25B

Medical - Diagnostics & Research

Next Earning date - 23 Oct 2024

25B

Medical - Diagnostics & Research

Next Earning date - 23 Oct 2024

297.72USD
Shape2.48 ( 0.84%)
favorite-chart

Relative Strenght

79
favorite-chart

Volume Buzz

-11%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

14%

Quote Panel

Shape
Updated October 21, 2024
1W 0.97 % 1M 0.48 % 3M -12.42 % 1Y 33.61 %

Key Metrics

Shape
  • Market Cap

    24.66B


  • Shares Outstanding

    82.82M


  • Share in Float

    82.05M


  • Dividende

    0


  • Earning Date

    23 Oct 2024


  • Price Target

    297.72


  • Average Volume

    569075


  • Beta

    1.22


  • Range

    222.32-347.72


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.iconplc.com


  • Sector

    Healthcare


Fundamentals

Shape

21.30x

P/E Ratio

2.96x

P/S Ratio

2.57x

P/B Ratio

0.4

Debt/Equity

8.6%

Net Margin

$8.6

EPS

How ICLR compares to sector?

P/E Ratio

Relative Strength

Shape

ICLR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$9B

Shape330%

2025-Revenue

$11.83

Shape565%

2025-EPS

$2B

Shape279%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Leerink Partners

initialise

Previous: Not converted

2024-09-18

Now: Outperform

Goldman Sachs

initialise

Previous: Not converted

2024-06-06

Now: Buy

Barclays

upgrade

Previous: Equal-Weight

2023-01-13

Now: Overweight

Bank of America Securities

upgrade

Previous: Not converted

2022-11-09

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+18%

3
vs 2.55

Q4.22

arrow
arrow

+19%

3.13
vs 2.63

Q1.23

arrow
arrow

+5%

2.9
vs 2.76

Q2.23

arrow
arrow

+9%

3.11
vs 2.86

Q3.23

arrow
arrow

+10%

3.3
vs 3

Q4.23

arrow
arrow

+11%

3.46
vs 3.13

Q1.24

arrow
arrow

+20%

3.47
vs 2.9

Q2.24

arrow
arrow

+21%

3.75
vs 3.11

Q3.24

arrow
arrow

+17%

3.85
vs 3.3

Q4.24

arrow
arrow

+16%

4.01
vs 3.46

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+4%

1.9B  vs 1.9B

Q4.22

arrow
arrow

+4%

2B  vs 1.9B

Q1.23

arrow
arrow

+4%

2B  vs 1.9B

Q2.23

arrow
arrow

+4%

2B  vs 1.9B

Q3.23

arrow
arrow

+6%

2.1B  vs 1.9B

Q4.23

arrow
arrow

+5%

2.1B  vs 2B

Q1.24

arrow
arrow

+6%

2.1B  vs 2B

Q2.24

arrow
arrow

+5%

2.1B  vs 2B

Q3.24

arrow
arrow

+4%

2.1B  vs 2.1B

Q4.24

arrow
arrow

+5%

2.2B  vs 2.1B

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+2%

0.02
vs 0.01

Q4.22

arrow
arrow

+1%

0.01
vs 0.02

Q1.23

arrow
arrow

+1%

0.01
vs 0.01

Q2.23

arrow
arrow

+1%

0.01
vs 0.01

Q3.23

arrow
arrow

+2%

0.02
vs 0.01

Q4.23

arrow
arrow

+2%

0.02
vs 0.02

Q1.24

arrow
arrow

+2%

0.02
vs 0.02

Q2.24

arrow
arrow

+2%

0.02
vs 0.02

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

490

490
vs 510

-4%

Q4.22

arrow
arrow

534

534
vs 490

9%

Q1.23

arrow
arrow

540

540
vs 534

1%

Q2.23

arrow
arrow

540

540
vs 540

NA

Q3.23

arrow
arrow

558

558
vs 540

3%

Q4.23

arrow
arrow

601

601
vs 558

8%

Q1.24

arrow
arrow

649

649
vs 601

8%

Q2.24

arrow
arrow

664

664
vs 649

2%

Earnings Growth

Latest News